Kairos Pharma KAPA
NYSE KAPA
$0.54 -0.06 (-10.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Kairos Pharma (KAPA) Operating Income (2023 - 2025)

Updated

Kairos Pharma's Operating Income was -$5.57 million in FY2025, compared with -$2.34 million in FY2024.

Analysis

Kairos Pharma (KAPA) Operating Income (2023 - 2025) Analysis & Trends

  • Per Business Quant data, Operating Income in earlier years was -$2.34 million in FY2024 and -$1.71 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 6.18 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn 6.43 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 3.16 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -10.39 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 4.27 Bn
10 Kairos Pharma 10.50 Mn -1.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1.46 Mn
Mar 31, 2025 -1.27 Mn
Dec 31, 2024 -1.45 Mn
Sep 30, 2024 -383,000.00
Jun 30, 2024 -222,000.00
Mar 31, 2024 -287,000.00
Dec 31, 2023 -1.09 Mn
Sep 30, 2023 -287,000.00
API Access

Kairos Pharma Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=KAPA&period=max&api_key=YOUR_API_KEY